Lvw Advisors, LLC Genmab A/S Transaction History

Lvw Advisors, LLC

$771 Million
Q3 2024

A detailed history of Lvw Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Lvw Advisors, LLC holds 12,333 shares of GMAB stock, worth $253,936. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,333

Previous 14,606 15.56%

Holding current value

$253,936

Previous $367,000 18.26%

% of portfolio

0.04%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$23.84 - $28.48 $54,188 - $64,735	-2,273 Reduced 15.56%	12,333 $300,000
Q2 2024 Jul 15, 2024	SELL	$25.13 - $30.27 $4,548 - $5,478	-181 Reduced 1.22%	14,606 $367,000
Q1 2024 Apr 17, 2024	BUY	$26.43 - $32.77 $4,255 - $5,275	161 Added 1.1%	14,787 $442,000
Q4 2023 Jan 12, 2024	SELL	$27.94 - $35.44 $11,287 - $14,317	-404 Reduced 2.69%	14,626 $465,000
Q3 2023 Oct 10, 2023	SELL	$35.27 - $42.24 $60,346 - $72,272	-1,711 Reduced 10.22%	15,030 $530,000
Q2 2023 Jul 14, 2023	SELL	$37.4 - $42.94 $13,838 - $15,887	-370 Reduced 2.16%	16,741 $636,000
Q1 2023 May 02, 2023	SELL	$34.88 - $43.22 $22,079 - $27,358	-633 Reduced 3.57%	17,111 $646,000
Q4 2022 Jan 18, 2023	SELL	$33.8 - $47.06 $100,791 - $140,332	-2,982 Reduced 14.39%	17,744 $0
Q3 2022 Oct 13, 2022	BUY	$31.52 - $373.61 $472 - $5,604	15 Added 0.07%	20,726 $666,000
Q2 2022 Jul 22, 2022	BUY	$26.83 - $38.57 $106,837 - $153,585	3,982 Added 23.8%	20,711 $673,000
Q1 2022 May 02, 2022	SELL	$30.95 - $39.68 $55,462 - $71,106	-1,792 Reduced 9.68%	16,729 $605,000
Q4 2021 Jan 26, 2022	SELL	$35.87 - $47.12 $33,000 - $43,350	-920 Reduced 4.73%	18,521 $733,000
Q3 2021 Nov 02, 2021	SELL	$41.55 - $48.72 $21,813 - $25,578	-525 Reduced 2.63%	19,441 $850,000
Q2 2021 Jul 15, 2021	SELL	$32.88 - $44.57 $197 - $267	-6 Reduced 0.03%	19,966 $815,000
Q1 2021 Apr 19, 2021	BUY	$30.92 - $44.4 $99,005 - $142,168	3,202 Added 19.09%	19,972 $656,000
Q4 2020 Feb 04, 2021	SELL	$33.66 - $40.76 $75,061 - $90,894	-2,230 Reduced 11.74%	16,770 $682,000
Q3 2020 Oct 29, 2020	BUY	$33.07 - $38.68 $14,385 - $16,825	435 Added 2.34%	19,000 $696,000
Q2 2020 Aug 11, 2020	SELL	$20.05 - $33.89 $56,220 - $95,027	-2,804 Reduced 13.12%	18,565 $629,000
Q1 2020 Apr 23, 2020	BUY	$17.15 - $25.22 $95,062 - $139,794	5,543 Added 35.02%	21,369 $453,000
Q4 2019 Feb 10, 2020	BUY	$18.88 - $24.14 $111,769 - $142,908	5,920 Added 59.76%	15,826 $353,000
Q3 2019 Oct 22, 2019	BUY	$18.0 - $21.38 $178,308 - $211,790	9,906 New	9,906 $201,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account